Human testing: Sass and Needleman respond to industry [6]

Environmental Health Perspectives

Volumn 112, Issue 6, 2004, Pages

  Sass, Jennifer B ^a   Needleman, Herbert L ^b  

^a NATURAL RESOURCES DEFENSE COUNCIL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPYRIFOS; ENVIRONMENTAL CHEMICAL; INDUSTRIAL CHEMICAL; ORGANOPHOSPHATE PESTICIDE;

BEHAVIOR DISORDER; CARCINOGENICITY; CHOLINESTERASE INHIBITION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL PROTECTION; EXPERIMENTATION; FETOTOXICITY; HUMAN; LETTER; MEDICAL ETHICS; MEDICOLEGAL ASPECT; NEUROTOXICITY; POPULATION RISK; PRIORITY JOURNAL; TOXICITY TESTING;

ADULT; BIOLOGICAL MARKERS; CHEMICAL INDUSTRY; CHILD; CHILD WELFARE; CHOLINESTERASES; EMBRYONIC AND FETAL DEVELOPMENT; ETHICS, PROFESSIONAL; FEMALE; HUMAN EXPERIMENTATION; HUMANS; NERVOUS SYSTEM; NO-OBSERVED-ADVERSE-EFFECT LEVEL; PESTICIDES; PREGNANCY; PUBLIC POLICY; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SAMPLE SIZE;

EID: 2442425434     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (19)

1. Aldridge JE, Seidler FJ, Slotkin TA. 2004. Developmental exposure to chlorpyrifos elicits sex-selective alterations of serotonergic synaptic function in adulthood: critical periods and regional selectivity for effects on the serotonin transporter, receptor subtypes, and cell signaling. Environ Health Perspect 112:148-155.
2. AMVAC. 1997. Dichlorvos: A Single Blind, Placebo Controlled, Randomized Study to Investigate the Effects of Multiple Oral Dosing on Erythrocyte Cholinesterase Inhibition in Healthy Male Volunteers. Report No CTL/P/5392. Study No. XH6063. MRID No. 442488-01. Newport Beach, CA:AMVAC Chemical Corporation.
3. Berkowitz GS, Wetmur JG, Birman-Deych E, Obel J, Lapinski RH, Godbold JH, et al. 2004. In utero pesticide exposure, maternal paraoxonase activity, and head circumference. Environ Health Perspect 112:388-391.
4. Charnley G, Patterson J. 2004. Ethical standards of studies involving human subjects [Letter]. Environ Health Perspect 112-A152-A153.
5. Chart IS, Manley A, Youngren SH. 2004. Study criticisms unjustified [Letter]. Environ Health Perspect 112:A151-A152.
6. Haines RG. 1971. Ingestion of Aldicarb by Human Volunteers: A Controlled Study of the Effect of Aldicarb on Man. Union Carbide Corporation Study No. ALD-03-77-2215. MRID No. 00101911. HED Doc. Nos. 007601, 010450. Washington, DC:U.S. Environmental Protection Agency.
7. Icenogle LM, Christopher NC, Blackwelder WP, Caldwell DP, Qiao D, Seidler FJ, et al. 2004. Behavioral alterations in adolescent and adult rats caused by a brief subtoxic exposure to chlorpyrifos during neurulation. Neurotoxicol Teratol 26(1):95-101.
8. Meyer A, Seidler FJ, Aldridge JE, Tate CA, Cousins MM, Slotkin TA. 2004a. Critical periods for chlorpyrifos-induced developmental neurotoxicity: alterations in adenylyl cyclase signaling in adult rat brain regions after gestational or neonatal exposure. Environ Health Perspect 112:295-301
9. Meyer A, Seidler FJ, Slotkin TA. 2004b. Developmental effects of chlorpyrifos extend beyond neurotoxicity: critical periods for immediate and delayed-onset effects on cardiac and hepatic cell signaling. Environ Health Perspect 112:170-178.
10. McAllister RS. 2004. Statement of CropLife America on pesticide testing involving human subjects [Letter]. Environ Health Perspect 112:A154-A155.
11. NRC (National Research Council). 2004. Intentional Human Dosing Studies for EPA Regulatory Purposes: Scientific and Ethical Issues. Washington, DC:National Academies Press. Available: http://www.nap.edu/books/0309091721/html/ [accessed 31 March 2004].
12. Perera FP, Rauh V, Tsai WY, Kinney P, Camann D, Barr D, et al. 2003. Effects of transplacental exposure to environmental pollutants on birth outcomes in a multiethnic population. Environ Health Perspect 111:201-205.
13. Sass JB, Needleman HL. 2004. Industry testing of toxic pesticides on human subjects concluded "no effect," despite the evidence [Letter]. Environ Health Perspect 112:A150-A151.
14. Tobia A, Ayers A, Blacker A, Hodges L, Carmichael N. 2004. Aldicarb study misrepresented in human testing debate [Letter]. Environ Health Perspect 112:A155-A156.
15. U.S. EPA. 1998a. EPA Statement on Human Testing. Washington, DC:U.S. Environmental Protection Agency. Available: http://www.epa.gov/oscpmont/sap/1998/december/epastmt.htm [accessed 31 March 2004].
16. U.S. EPA 1998b. Memorandum from JE Stewart, Registration Action Branch II, to C Scheltema, Risk Characterization and Analysis Branch. Review of Toxicity Studies on DDVP Using Human Volunteers (Data Evaluation Reports for MRID Nos. 44317901, 442488-01, and 442488-02). Washington, DC:U.S. Environmental Protection Agency.
17. U.S. EPA. 2000. Comments on the Use of Data from the Testing of Human Subjects. A Report by the Scientific Advisory Board and the FIFRA Scientific Advisory Panel. EPA-SAB-EC-00-017. Washington, DC:U.S. Environmental Protection Agency. Available: http://www.epa.gov/sab/pdf/ec0017.pdf [accessed 31 March 2004].
18. Whyatt RM, Barr DB, Camann DE, Kinney PL, Barr JR, Andrews HF, et al. 2003. Contemporary-use pesticides in personal air samples during pregnancy and blood samples at delivery among urban minority mothers and newborns. Environ Health Perspect 111:749-756.
19. Wyld PJ, Watson CE, Nimmo WS, Watson N. 1992. A Safety and Tolerability Study of Aldicarb at Various Dose Levels in Healthy Male and Female Volunteers. Rhone-Poulenc, Lyon, France. Inveresk Clinical Research Report No. 7786. MRID No. 42373-01. HED Doc No 010459. Washington, DC:U.S. Environmental Protection Agency.